JRS Pharma Oy is a Finnish OY based in Nastola, operating in the Manufacture of other chemical products n.e.c. sector. Incorporated in 1989, the company has 29 employees and reported revenue of 19,8 milj. € in its latest annual filing.
Yhtiön toimialana on farmaseuttisten apuaineiden, ravintokuitujen sekä muiden teollisten kemikaalien valmistus, jakelu ja myynti. Toimintaansa varten yhtiö voi omistaa ja vuokrata kiinteistöjä ja kiinteistöosakkeita.
In its most recent annual report (2024), JRS Pharma Oy reported revenue of 19,8 milj. €, an increase of 11% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net profit of 722,9 t. €, and the EBITDA margin stood at 30%.
At the end of 2024, equity financed 39.8% of the balance sheet, and current assets covered short-term debt 3.5 times.
Frequently asked questions
What is the Y-tunnus number of JRS Pharma Oy?
JRS Pharma Oy is registered with PRH / YTJ under Y-tunnus 0759910-8.
What is the revenue of JRS Pharma Oy?
JRS Pharma Oy reported revenue of 19,8 milj. € in 2024.
How many employees does JRS Pharma Oy have?
JRS Pharma Oy employs 29 people as of the latest annual report.
Who is the CEO of JRS Pharma Oy?
Johanna Fredrika Viitanen is the CEO of JRS Pharma Oy, in role since 2018.
Who is the chairman of JRS Pharma Oy?
Josef Otto Rettenmaier chairs the board of JRS Pharma Oy, in role since 2018.
